AAPM 2026 | VANCOUVER, BC

SCIENTIFIC EVIDENCE

July 19-22

ORAL PRESENTATIONS

MONDAY, JULY 20 5:10 PM \| ROOM 220	A Patient-specific Digital Twin for Adaptive Radiotherapy of NSCLC Lauren Tressel, MSc., et al Yale New Haven Health VIEW HERE
TUESDAY, JULY 21 9:10 AM \| ROOM 109	Evaluating Biology-guided Radiotherapy (BgRT) dose conformality for complex PET-avid targets under static and motion conditions Murat Surucu, Ph.D., et al., Stanford Healthcare VIEW HERE
WEDNESDAY, JULY 22 12:00 PM \| ROOM 220	Robustness of X2 Anchor Point Tracking to Breathing Pattern Changes during Biology-guided Radiotherapy Murat Surucu, Ph.D., et al., Stanford Healthcare *VIEW HERE*

FEATURED POSTERS

SUNDAY, JULY 19 3:15 PM \| POSTER LOUNGE	Evaluation of a prototype PET-based Biology-guided Therapy (BGRT) System with Anchor Point Tracking Treatment Delivery Using Software Simulation RefleXion R&D VIEW HERE
SUNDAY, JULY 19 3:15 PM \| POSTER LOUNGE	Feasibility of Biology-guided Radiotherapy of small tumors with extended field of view PET detectors RefleXion R&D VIEW HERE
SUNDAY, JULY 19 3:15 PM \| POSTER LOUNGE	PET Signal Guidance in Biology-guided Radiotherapy: Impact of Deblurring and Anchor-Point Tracking on Dosimetry Murat Surucu, Ph.D., et al., Stanford Healthcare VIEW HERE
SUNDAY, JULY 19 3:15 PM \| POSTER LOUNGE	Pre-clinical evaluation of an Enhanced PET-based Biology-guided radiotherapy platform: Phantom experiments for inhomogeneous tracer-avid targets Huixiao Chen, Ph.D., et al., Yale New Haven Health VIEW HERE
SUNDAY, JULY 19 AVAILABLE ONLINE	Dosimetric performance for large PET-Avid tumors enabled by Anchor Point Tracking and extended PET Field-of-View RefleXion R&D VIEW HERE
SUNDAY, JULY 19 AVAILABLE ONLINE	Evaluation of OAR sparing and influence on upgraded BgRT platform Thomas Banks, Ph.D., et al., University of Texas Southwestern VIEW HERE
SUNDAY, JULY 19 AVAILABLE ONLINE	Robustness of BgRT delivery to sudden patient shifts evaluated in the new X2 platform RefleXion R&D VIEW HERE
SUNDAY, JULY 19 AVAILABLE ONLINE	Multi-target Treatment Planning and Delivery on a PET-linac Platform: Dosimetric Robustness and Efficiency in OMD Radiotherapy Robert Timmerman, MD, et al., University of Texas Southwestern VIEW HERE

POSTERS

SUNDAY, SEPTEMBER 19 3:15 PM \| POSTER LOUNGE	Commissioning a Plastic Scintillator Detector for Clinical Use in IGRT and BgRT on a PET linac Yiu-Hsin Change, Ph.D., et al., Yale New Haven Health VIEW HERE
SUNDAY, SEPTEMBER 19 AVAILABLE ONLINE	Dynamic Jaw Correction of Gravity-Induced System Structural Error on RefleXion X1 for Improved Small Target Dosimetry RefleXion R&D VIEW HERE
SUNDAY, SEPTEMBER 19 AVAILABLE ONLINE	Evaluation of Biology-guided Radiotherapy Treatment Delivery Patterns Based on Beamlet Sequence Log Data from Daily Treatments Chunhui Han, Ph.D., et al., City of Hope VIEW HERE
SUNDAY, SEPTEMBER 19 AVAILABLE ONLINE	Predictive Value of Synthetic PET Imaging for Assessing Biology-guided Radiotherapy Feasibility: Results from a Prospective Imaging Study Chunhui Han, Ph.D., et al., City of Hope VIEW HERE
SUNDAY, SEPTEMBER 19 AVAILABLE ONLINE	Plan Quality Comparison between C-Arm and PET-Linac on Pancreatic Cases to Consider Known Abdominal Imaging Advantages Sameer Taneja, Ph.D., et al., Yale New Haven Health VIEW HERE

SCINTIX THERAPY

SCINTIX® technology is a novel therapy for patients with tumors in the lung or bone arising from primary and metastatic cancer. This breakthrough technology uses live, continuously updated data throughout the entire treatment session to determine where to deliver radiotherapy.

The X2 platform is FDA-cleared for primary and metastatic lung and bone tumors. The new Anchor Point™ Tracking algorithm is under development and is not yet available for sale.

LEARN MORE

DISCLOSURES

As a health care professional attendee of this event, you understand and agree that for purposes of complying with RefleXion’s mandatory transparency reporting obligations under the Patient Protection and Affordable Care Act (together with any regulations and official guidelines promulgated thereunder) and any applicable state reporting requirements, RefleXion may collect, aggregate and report any and all payments made pursuant to this event.